Course Materials (Online Syllabus)

Below you will find the educational information presented during the IDEAL® CME/CE activity at AAFP, held on Ocotber 22-25, 2014 in Washington, DC – One Size Does Not Fit All: Developing a Collaborative Care Plan with Your Patient to Reduce Obesity and Improve Outcomes. This material is provided for your information only. CME/CE credit was offered for participating during the live event only.

To download a PDF copy of the panels and transcripts, click here
To download a PDF copy of the clinical pearl handouts, click here

PROGRAM PANELS
Panel 1: OBESITY: IT'S ALL ABOUT THE NUMBERS
References can be found on the
Resources page
Panel 1: OBESITY: IT'S ALL ABOUT THE NUMBERS
True or False. Patients should be encouraged to jump start weight reduction plans by utilizing quick loss diets, followed by transition to a more reasonable weight loss approach.
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 2: THE ROLE OF MOTIVATIONAL INTERVIEWING IN TREATING OBESITY
References can be found on the
Resources page
Panel 2: THE ROLE OF MOTIVATIONAL INTERVIEWING IN TREATING OBESITY
True or False. Motivational Interviewing is a therapeutic intervention study aimed at establishing a direct line of information and guidance from the clinician/expert to the patient to increase compliance to lifestyle changes.
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 3: OBESITY THERAPEUTIC OPTIONS INCLUDING PHARMACOTHERAPY: PHYSICIAN AND PATIENT AWARENESS & EXPECTATIONS
References can be found on the
Resources page
Panel 3: OBESITY THERAPEUTIC OPTIONS INCLUDING PHARMACOTHERAPY: PHYSICIAN AND PATIENT AWARENESS & EXPECTATIONS
Of patients who meet the criteria for pharmacotherapy for treatment of obesity, consisting of a body mass index of > 30 or a BMI of >27 with comorbidities, what percentage are currently receiving pharmacotherapy or surgical intervention?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 4: THE PAST, PRESENT, AND FUTURE OF OBESITY THERAPEUTICS
References can be found on the
Resources page
Panel 4: THE PAST, PRESENT, AND FUTURE OF OBESITY THERAPEUTICS
True or False. Clinical studies of novel anti-obesity pharmacotherapy demonstrated > 10% body weight loss results over a 1 year period.
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 5: LOSE 5 TO STAY ALIVE
References can be found on the
Resources page
Panel 5: LOSE 5 TO STAY ALIVE
Which of the following comorbidities can benefit from as little as a 5% reduction of body weight?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---

SPONSORSHIP
Supported in part by a grant to the AAFP from Novo Nordisk and Takeda Pharmaceuticals.
IDEAL®technology for this activity is provided by Educational Awareness Solutions.